Awards Recognise Women Health Innovators
Date Posted – 13 May 2021 Four outstanding women have been recognised for their incredible work across Victoria’s health technology sector as Australia dealt with COVID-19 in 2020. Victoria’s medical and scientific communities made an important contribution to…
Imagion Biosystems and Patrys to Collaborate on Brain Tumor Imaging
Date Posted – 3 May 2021 Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, and Patrys Limited (ASX: PAB), a therapeutic antibody development company, are pleased to announce a…
New Director to Support COVID Vaccine Development at Sementis
Date Posted – 27 April 2021 Adelaide-based Australian biotechnology company Sementis has appointed internationally-renowned Dr Anna Lavelle as an Independent Director. Dr Lavelle was named among the world’s 100 most influential people in global life sciences by Scientific…
Victoria announces $50m to fund mRNA COVID-19 vaccine production in Australia, paving way for Pfizer-style manufacturing
Date Posted – 21 April 2021 The Victorian government is providing $50 million to “kickstart” domestic manufacturing of mRNA vaccine technology. It will take at least 12 months for any of the vaccines to be made in Australia,…
Mutiple Dose Part Of Ad-214 Phase I Trial Commenced – AdAlta
Date Posted – 19 April 2021 AdAlta Limited (ASX:1AD), the clinical stage biotechnology company developing novel medicines using its i-body platform is pleased to announce that the first cohort of healthy volunteers have received the first of three…
First Patients Benefit from Victoria’s Non-Invasive Gamma Knife
Date Posted – 8 April 2021 The first Gamma Knife to be installed in Victoria, at Peter MacCallum Cancer Centre, is now fully operational, with the first patients to receive the non-invasive radiosurgery sharing their experiences. The Gamma…
Mr Peter Giannopoulos appointed as CEO of Cell Therapies Pty Ltd
Date Posted – 6 April 2021 Cell Therapies Pty Ltd, a leading provider of cell and gene therapy products in the Asia Pacific region, is delighted to announce the appointment of Mr Peter Giannopoulos as the company’s new Chief Executive…
University of Sydney receives approval to start COVALIA, a Phase 1 Clinical trial of COVIGEN, a New COVID-19 Vaccine Candidate in Australia
Date Posted – 26 March 2021 Date Published – 22 March 2021 First needle-free DNA-based COVID-19 candidate vaccine to be tested in Australia in a phase 1 trial in healthy subjects aged 18 to 75 years old •…
PI expands manufacturing facilities with new medtech wing in Melbourne
Date Posted – 26 March 2021 Australia’s Minister for Industry, Science and Technology Karen Andrews visited Planet Innovation (PI) to officially open a new 1,000m2 medtech manufacturing wing in our Melbourne facility. The new wing is part of PI’s…
Latest COVID-19 Advice for Offices
Date Posted – 25 March 2021 The relaxation of COVID settings this week reinforces the need for good record keeping. The Victorian Government announced on Tuesday that the 75 per cent cap on office workers will be removed…
Sleeptite launches ground-breaking real-time aged care monitoring and alert technology (in collaboration with RMIT)
Date Posted – 24 March 2021 Date Released – 19 March 2021 Melbourne-based research and advanced manufacturing company Sleeptite, today launched REMi – a world first, non-invasive resident monitoring and alert system that has the potential to revolutionise…
Parliament passes casual employee definition and addresses casual employment uncertainty
Date Posted – 23 March 2021 Written by – Karl Luke and Bridget Nunn There has been significant press around the government’s agenda to reform large parts of the Fair Work regime, most of which failed in the Senate.…
